SEPAR guidelines for lung cancer staging.

Area of Science:

• Oncology
• Medical Imaging
• Thoracic Surgery

Background:

• The International Association for the Study of Lung Cancer (IASLC) TNM classification is crucial for lung cancer staging.
• Previous classifications required updates to reflect advancements in diagnostic techniques and global patient data.
• Accurate staging is fundamental for effective lung cancer treatment strategies.

Purpose of the Study:

• To introduce and explain the latest IASLC TNM classification for lung cancer.
• To highlight changes in tumor descriptors, group staging, and lymph node mapping.
• To provide recommendations on updated staging procedures and future molecular staging integration.

Main Methods:

• Analysis of global patient data by the IASLC.
• Incorporation of updated tumor size descriptors and new group staging.
• Development of a novel lymph node map for improved N component classification.
• Integration of advanced imaging techniques like PET/CT, EBUS, and EUS in the staging algorithm.

Main Results:

• Revised TNM classification with updated tumor size descriptors and new staging groups.
• Introduction of a new lymph node map to enhance N component classification.
• Emphasis on PET/CT, EBUS, and EUS for comprehensive staging and re-staging.
• Recommendation for systematic lymph node dissection for precise surgical-pathological classification.

Conclusions:

• The updated IASLC TNM classification provides a more refined system for lung cancer staging.
• Advanced imaging and minimally invasive techniques improve the accuracy of staging and re-staging.
• Future molecular staging is anticipated to further enhance diagnostic precision and therapeutic decision-making.